Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...
BOULDER, CO / ACCESS Newswire / February 4, 2026 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant ...
Laboratory Standardization MISSISSAUGA, ON / ACCESS Newswire / February 4, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, ...
Approved Tyrosine Kinase Inhibitor for Metastatic Mast Cell TumorAUSTIN, Texas--(BUSINESS WIRE)--#animalhealth--VMD Sciences, the leader in global veterinary pharmaceutical access services, announced ...
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible ...
SFC Group, LLC, an award-winning healthcare marketing agency, today announced the launch of its new Seriously Campaign — an ...
Elevating the Future of Healthcare Human ResourcesSan Diego, CA – The Healthcare HR Summit 2026, an exclusive invitation-only ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / February 3, 2026 / Black Book™, the independent healthcare IT research firm, today released its 2026 rankings for secure messaging, HIPAA-compliant texting, ...
Collaborative Nature Communications study with The University of Queensland, Yale School of Medicine, and Nucleai examines how tumor cell positioning and glucose use predict which NSCLC patients ...
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and ...
Lōkahi Therapeutics today announced the participation of the University of Georgia’s Student Industry Fellows Program in its ai² (actual intelligence) Futures Lab program for the Spring 2026 semester.
Zonsen PepLib Biotech Inc. (“PepLib”) today announced that it has entered a global research and development (R&D) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results